Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-12 7:15 PM View:  | VaxGen Inc. (DDXS) | 27-Jan-12 | Market Sale | 59,340 | $0.22 | $13,155.70 | (100%) 59.34K to 0 | 36% |
| 20-Jan-12 6:18 PM View: | VaxGen Inc. (DDXS) | 19-Jan-12 | Market Sale | 20,000 | $0.20 | $4,000.00 | (25%) 79.34K to 59.34K | 29% |
| 20-Jan-12 6:18 PM View: | VaxGen Inc. (DDXS) | 18-Jan-12 | Market Sale | 118,800 | $0.21 | $25,233.10 | (60%) 198.14K to 79.34K | 33% |
| 04-Jan-12 7:24 PM View: | Seattle Genetics Inc. (SGEN) | 30-Dec-11 | Exercise (in-the money or at-the-money) | 68,006 | $6.25 | $425,038.00 | 14% 471.12K to 539.13K | |
| 04-Nov-11 8:34 PM View: | Trimeris Inc. (GEVA) | 02-Nov-11 | Grant | 159,391 | -- | -- | 32% 491.85K to 651.24K | |
| 05-Jul-11 6:29 PM View: | Adolor Corp. (ADLR) | 30-Jun-11 | Disposition (other) | 2,902 | -- | -- | (100%) 2.9K to 0 | |
| 05-Jul-11 6:03 PM View: | Trimeris Inc. (GEVA) | 30-Jun-11 | Disposition (other) Duplicate | 9,852 | -- | -- | (3%) 316.36K to 306.51K | |
| 05-Jul-11 6:07 PM View: | Ardea Biosciences, Inc. (RDEA) | 30-Jun-11 | Disposition (other) Duplicate | 9,301 | -- | -- | (7%) 136.01K to 126.71K | |
| 05-Jul-11 6:11 PM View: | Seattle Genetics Inc. (SGEN) | 30-Jun-11 | Disposition (other) | 10,766 | -- | -- | (2%) 481.89K to 471.12K | |
| 05-Jul-11 6:26 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 30-Jun-11 | Disposition (other) | 6,992 | -- | -- | (100%) 6.99K to 0 | |
| 05-Jul-11 6:34 PM View: | AP Pharma Inc. (HRTX) | 30-Jun-11 | Disposition (other) | 1,786 | -- | -- | (100%) 1.79K to 0 | |
| 05-Jul-11 6:25 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Jun-11 | Disposition (other) Duplicate | 9,590 | -- | -- | (13%) 72.0K to 62.41K | |
| 05-Jul-11 6:19 PM View: | Incyte Corp (INCY) | 30-Jun-11 | Disposition (other) Duplicate | 11,664 | -- | -- | (5%) 239.26K to 227.59K | |
| 05-Jul-11 6:22 PM View: | Genomic Health Inc. (GHDX) | 30-Jun-11 | Disposition (other) Duplicate | 7,280 | -- | -- | (4%) 194.41K to 187.13K | |
| 09-Jun-11 5:32 PM View: | Genomic Health Inc. (GHDX) | 09-Jun-11 | Market Purchase | 49 | $26.25 | $1,286.49 | < 1% 1.55M to 1.55M | 217% |
| 09-Jun-11 5:32 PM View: | Genomic Health Inc. (GHDX) | 08-Jun-11 | Market Purchase | 27 | $26.13 | $705.52 | < 1% 1.55M to 1.55M | 219% |
| 09-Jun-11 5:32 PM View: | Genomic Health Inc. (GHDX) | 07-Jun-11 | Market Purchase | 43 | $26.16 | $1,124.82 | < 1% 1.55M to 1.55M | 218% |
| 01-Jun-11 5:23 PM View: | Genomic Health Inc. (GHDX) | 01-Jun-11 | Market Purchase | 44 | $27.49 | $1,209.45 | < 1% 971.23K to 971.27K | 203% |
| 01-Jun-11 5:23 PM View: | Genomic Health Inc. (GHDX) | 31-May-11 | Market Purchase | 34 | $27.48 | $934.17 | < 1% 971.19K to 971.23K | 203% |
| 01-Jun-11 5:23 PM View: | Genomic Health Inc. (GHDX) | 27-May-11 | Market Purchase | 34 | $27.04 | $919.22 | < 1% 971.16K to 971.19K | 208% |
| 13-May-11 5:49 PM View: | ViroPharma Inc. (VPHM) | 10-May-11 | Disposition (other) | 101,047 | -- | -- | (96%) 105.8K to 4.75K | |
| 31-Mar-11 5:59 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 30-Mar-11 | Market Purchase | 309 | $21.98 | $6,791.79 | 5% 6.68K to 6.99K | 57% |
| 29-Oct-10 5:31 PM View: | Adolor Corp. (ADLR) | 29-Oct-10 | Market Sale | 14 | $1.18 | $16.56 | (< 1%) 2.92K to 2.9K | (314%) |
| 29-Oct-10 5:31 PM View: | Adolor Corp. (ADLR) | 28-Oct-10 | Market Sale | 33 | $1.19 | $39.22 | (1%) 2.95K to 2.92K | (313%) |
| 29-Oct-10 5:31 PM View: | Adolor Corp. (ADLR) | 27-Oct-10 | Market Sale | 30 | $1.29 | $38.79 | (1%) 2.98K to 2.95K | (279%) |
| 23-Sep-10 5:46 PM View: | Incyte Corp (INCY) | 23-Sep-10 | Market Sale | 5,722 | $14.86 | $85,033.50 | (< 1%) 742.17K to 736.45K | (495%) |
| 23-Sep-10 5:46 PM View: | Incyte Corp (INCY) | 22-Sep-10 | Market Sale | 7,233 | $14.71 | $106,410.00 | (< 1%) 749.41K to 742.17K | (501%) |
| 23-Sep-10 5:46 PM View: | Incyte Corp (INCY) | 21-Sep-10 | Market Sale | 19,433 | $14.94 | $290,387.00 | (3%) 768.84K to 749.41K | (491%) |
| 11-Aug-10 5:31 PM View: | Incyte Corp (INCY) | 10-Aug-10 | Market Sale | 2,812 | $14.00 | $39,364.20 | (< 1%) 1.1M to 1.1M | (531%) |
| 11-Aug-10 5:31 PM View: | Incyte Corp (INCY) | 09-Aug-10 | Market Sale | 9,991 | $14.08 | $140,710.00 | (< 1%) 1.11M to 1.1M | (527%) |
| 17-Aug-09 4:10 PM View: | Genomic Health Inc. (GHDX) | 17-Aug-09 | Market Purchase | 1 | $19.60 | $19.60 | < 1% 388.37K to 388.37K | 335% |
| 17-Aug-09 4:10 PM View: | Genomic Health Inc. (GHDX) | 13-Aug-09 | Market Purchase | 33 | $19.99 | $659.66 | < 1% 388.33K to 388.37K | 327% |
| 12-Aug-09 4:38 PM View: | Genomic Health Inc. (GHDX) | 12-Aug-09 | Market Purchase | 14 | $19.70 | $275.76 | < 1% 970.63K to 970.64K | 333% |
| 04-May-10 8:51 PM View: | Seattle Genetics Inc. (SGEN) | 11-Aug-09 | Market Purchase | 798 | $10.75 | $8,578.50 | < 1% 481.09K to 481.89K | 581% |
| 12-Aug-09 4:38 PM View: | Genomic Health Inc. (GHDX) | 11-Aug-09 | Market Purchase | 21 | $19.36 | $406.64 | < 1% 970.61K to 970.63K | 341% |
| 12-Aug-09 4:38 PM View: | Genomic Health Inc. (GHDX) | 10-Aug-09 | Market Purchase | 10 | $19.49 | $194.91 | < 1% 970.6K to 970.61K | 338% |
| 26-May-09 4:12 PM View: | ViroPharma Inc. (VPHM) | 21-May-09 | Market Purchase | 24 | $6.08 | $146.01 | < 1% 317.36K to 317.38K | 726% |
| 22-May-09 4:16 PM View: | Genomic Health Inc. (GHDX) | 21-May-09 | Market Purchase | 3 | $17.82 | $53.47 | < 1% 776.38K to 776.39K | 374% |
| 20-May-09 5:35 PM View: | Seattle Genetics Inc. (SGEN) | 20-May-09 | Market Purchase | 3,710 | $9.72 | $36,061.20 | < 1% 477.38K to 481.09K | 619% |
| 22-May-09 4:16 PM View: | Genomic Health Inc. (GHDX) | 20-May-09 | Market Purchase | 22 | $17.99 | $395.71 | < 1% 776.36K to 776.38K | 370% |
| 20-May-09 5:28 PM View: | ViroPharma Inc. (VPHM) | 19-May-09 | Market Purchase | 52 | $5.99 | $311.62 | < 1% 634.29K to 634.34K | 738% |
| 20-May-09 5:28 PM View: | ViroPharma Inc. (VPHM) | 18-May-09 | Market Purchase | 56 | $5.97 | $334.16 | < 1% 634.24K to 634.29K | 742% |
| 15-May-09 4:19 PM View: | ViroPharma Inc. (VPHM) | 13-May-09 | Market Purchase | 279 | $5.46 | $1,522.70 | < 1% 316.3K to 316.57K | 821% |
| 11-May-09 5:10 PM View: | ViroPharma Inc. (VPHM) | 11-May-09 | Market Purchase | 61 | $5.86 | $357.36 | < 1% 421.09K to 421.15K | 758% |
| 11-May-09 5:44 PM View: | Genomic Health Inc. (GHDX) | 11-May-09 | Market Purchase | 33 | $19.48 | $642.86 | < 1% 970.2K to 970.23K | 334% |
| 11-May-09 5:10 PM View: | ViroPharma Inc. (VPHM) | 08-May-09 | Market Purchase | 83 | $5.92 | $491.67 | < 1% 421.01K to 421.09K | 748% |
| 11-May-09 5:44 PM View: | Genomic Health Inc. (GHDX) | 08-May-09 | Market Purchase | 19 | $19.67 | $373.74 | < 1% 970.18K to 970.2K | 337% |
| 11-May-09 5:10 PM View: | ViroPharma Inc. (VPHM) | 07-May-09 | Market Purchase | 138 | $5.72 | $789.67 | < 1% 420.87K to 421.01K | 778% |
| 11-May-09 5:44 PM View: | Genomic Health Inc. (GHDX) | 07-May-09 | Market Purchase | 36 | $19.54 | $703.42 | < 1% 970.14K to 970.18K | 340% |
| 05-Mar-09 5:51 PM View: | Incyte Corp (INCY) | 05-Mar-09 | Market Purchase | 5 | $2.16 | $10.79 | < 1% 568.89K to 568.89K | 3239% |